Jan. 16 2012
Source Page: The NHS atlas of variation in healthcare: reducing unwarranted variation to increase value and improve quality. 236 p.Found: ........................................74Map 5: Percentage of histologically con˜rmed non-small cell
Jul. 20 2023
Source Page: Non-technical summaries granted in 2023Found: cells, Gene Regulation, Stem Cell self-renewal, Stem cell niche, Organoids Animal types
May. 15 2023
Source Page: Scottish Donation and Transplant Group meeting - written updates: March 2023Found: Consultant/Principal Clinical Scientist rota supporting deceased donor kidney, SPK, islet and cardiac transplantation
Jul. 05 2023
Source Page: Glofitimab in the treatment of diffuse large B-cell lymphoma (DLBCL)Found: Glofitimab in the treatment of diffuse large B-cell lymphoma (DLBCL)
Apr. 24 2008
Source Page: Our inheritance, our future: realising the potential of genetics in the NHS progress review. 32 p.Found: Newborn screening for sickle cell is now fully implemented and covers the whole ¥ of England and is
Jul. 20 2023
Source Page: Non-technical summaries granted in 2023Found: Due to previous experience, cancer cell transplantation in the target tissue (orthotopic cell grafting
Oct. 10 2023
Source Page: RPC Register of Interests, September 2023Found: on the Board of Anthony Nolan – a UK charity that works in the areas of leukaemia and hematopoietic stem
Jul. 05 2023
Source Page: Dostarlimab in the treatment of endometrial cancerFound: ications, including graft -versus -host disease (GvHD), in people who have received a bone marrow (stem
Aug. 17 2023
Source Page: RPC Register of Interests, July 2023Found: on the Board of Anthony Nolan – a UK charity that works in the areas of leukaemia and hematopoietic stem
Jul. 05 2023
Source Page: Dostarlimab in the treatment of endometrial cancerFound: Dostarlimab is an anti -programmed cell death protein -1 (PD -1) immunoglobulin G4 (IgG4) humanised